Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Corin sounds profit warning due to Cormet slow-down

This article was originally published in Clinica

Executive Summary

Orthopaedic specialist Corin has warned investors that its pre-tax profit for fiscal 2008 will be "materially" lower than expected because of a drop in orders for its Cormet hip implants from US distributor Stryker. The Gloucester, UK-based firm said the number of Cormet implantations in 2008 were not enough for Stryker to re-order the devices in the fourth quarter. Corin added that Stryker (Kalamazoo, Michigan) would have enough implants in its existing inventory to cover its orders in the first fiscal quarter of 2009. As for the rest of 2009, Corin said Stryker would order extra implants as and when they were needed. The company also said that it does not expect its partner to purchase any more surgical instrumentation kits (needed to aid implantation of the Cormet device) during fiscal 2009.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel